BRIEF REPORT
Aplasia Cutis Congenita and Other Anomalies Associated with Methimazole Exposure During Pregnancy
Article first published online: 13 OCT 2011
DOI: 10.1111/j.1525-1470.2011.01572.x
© 2011 Wiley Periodicals, Inc.
Additional Information
How to Cite
RODRÍGUEZ-GARCÍA, C., GONZÁLEZ-HERNÁNDEZ, S., HERNÁNDEZ-MARTÍN, A., PÉREZ-ROBAYNA, N., SÁNCHEZ, R. and TORRELO, A. (2011), Aplasia Cutis Congenita and Other Anomalies Associated with Methimazole Exposure During Pregnancy. Pediatric Dermatology, 28: 743–745. doi: 10.1111/j.1525-1470.2011.01572.x
Publication History
- Issue published online: 15 NOV 2011
- Article first published online: 13 OCT 2011
- Abstract
- Article
- References
- Cited By
Abstract: Aplasia cutis congenita (ACC) is a congenital defect consisting of a circumscribed absence of skin that usually involves the scalp. The etiology is uncertain, and several teratogenic agents such as methimazole have been involved. We report two cases of ACC and other anomalies in newborns exposed to methimazole during pregnancy.

1525-1470/asset/PDE_left.gif?v=1&s=1299ee0db2f6355a4a3b185c5ee6579c15b0e598)
1525-1470/asset/PDE_right.gif?v=1&s=b6dee6f6511f21d924e3c0b0005944e0168ab2c0)
